Literature DB >> 8949717

Retinal blood flow indices in patients infected with human immunodeficiency virus.

C W Yung1, A Harris, S Massicotte, G Chioran, G Krombach, R Danis, S Wolf.   

Abstract

AIMS/
BACKGROUND: Abnormal blood flow dynamics are believed to contribute to the development of retinal microvascular disease in patients infected with human immunodeficiency virus (HIV). In this study, the scanning laser ophthalmoscope (SLO) was used, combined with fluorescein angiography, to measure retinal blood flow indices in HIV seropositive patients.
METHODS: Arteriovenous passage time (AVP) and perifoveal capillary blood flow velocity (CFV) were measured in 23 HIV infected patients and 23 control subjects with SLO fluorescein angiography.
RESULTS: No significant difference in AVP was found between the two groups. However, CFV was significantly reduced in HIV infected patients (p = 0.013).
CONCLUSION: Patients infected with HIV show abnormal haemodynamics at the level of the perifoveal capillaries.

Entities:  

Mesh:

Year:  1996        PMID: 8949717      PMCID: PMC505589          DOI: 10.1136/bjo.80.8.723

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  28 in total

1.  Ocular pathology of diabetes mellitus.

Authors:  M Yanoff
Journal:  Am J Ophthalmol       Date:  1969-01       Impact factor: 5.258

2.  Pathogenesis of cotton wool patches: a clinical study.

Authors:  E Chihara
Journal:  Jpn J Ophthalmol       Date:  1983       Impact factor: 2.447

3.  An analysis of retinal cotton-wool spots and cytomegalovirus retinitis in the acquired immunodeficiency syndrome.

Authors:  J S Pepose; M S Nestor; G N Holland; A J Cochran; R Y Foos
Journal:  Am J Ophthalmol       Date:  1983-01       Impact factor: 5.258

4.  Retinal cotton-wool patches in acquired immunodeficiency syndrome.

Authors: 
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

5.  Changes in red cell oxygen release capacity in diabetes mellitus.

Authors:  J Ditzel
Journal:  Fed Proc       Date:  1979-10

6.  Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome.

Authors:  B D Kuppermann; J G Petty; D D Richman; W C Mathews; S C Fullerton; L S Rickman; W R Freeman
Journal:  Am J Ophthalmol       Date:  1993-05-15       Impact factor: 5.258

7.  Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome.

Authors:  G N Holland; M S Gottlieb; R D Yee; H M Schanker; T H Pettit
Journal:  Am J Ophthalmol       Date:  1982-04       Impact factor: 5.258

8.  Immune-complex deposition in the eye in systemic lupus erythematosus.

Authors:  A J Aronson; N G Ordoñez; K R Diddie; J T Ernest
Journal:  Arch Intern Med       Date:  1979-11

9.  Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection.

Authors:  A Grefte; M van der Giessen; W van Son; T H The
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Acquired immune deficiency syndrome. Ocular manifestations.

Authors:  G N Holland; J S Pepose; T H Pettit; M S Gottlieb; R D Yee; R Y Foos
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

View more
  3 in total

1.  Red blood cell deformability in patients with human immunodeficiency virus infection.

Authors:  G A Athanassiou; A G Moutzouri; C A Gogos; A T Skoutelis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-05       Impact factor: 3.267

2.  Imaging of long-term retinal damage after resolved cotton wool spots.

Authors:  Maria Laura Gomez; Francesca Mojana; Dirk-Uwe Bartsch; William R Freeman
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

3.  Bilateral central retinal artery occlusion as presenting manifestation of human immunodeficiency virus infection.

Authors:  Reema Bansal; Sahil Jain; Vishali Gupta; Aman Sharma; Amanjit Bal; Sanjay Jain
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.